Recall
FDAHealthJanuary 21, 2025

The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories — Lorazepam Tablets, USP, 0.5mg, Unit Dose, 100 tablets per carton (10 x 10 blister packs), Rx only, The drug product contai

⚠️ Failed impurities/degradation specifications and Sub-potent Drug: Out-of-specification results were obtained during routine stability testing for Assay and Impurities.

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
January 21, 2025

Nationwide U.S. and Puerto rico

What's affected?

Product
Lorazepam Tablets, USP, 0.5mg, Unit Dose, 100 tablets per carton (10 x 10 blister packs), Rx only, The drug product contained in this package is from NDC # 69315-904 Leading Pharma, LLC., Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 26268 USA, NDC: 0904-6007-61
Lot code
N01424

Additional details

Lot #s: N01424, N01425, Exp 03/31/2025; N01659, N01660, Exp 08/31/2025; N01668, 09/2025; N01679, N01704, N01745, Exp 10/31/2025; N01856, Exp 02/28/2026; N01973, Exp 05/31/2026; N02079, Exp 08/31/2026.

What should I do?

Recommended action

Class II recall. Voluntary: Firm initiated Quantity affected: 82,281 cartons.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.